Advanced Medical and Dental Institute, Universiti Sains Malaysia, Penang, Malaysia.
Cancer Research Malaysia, Selangor, Malaysia.
Breast Cancer. 2024 May;31(3):496-506. doi: 10.1007/s12282-024-01564-8. Epub 2024 Mar 28.
Primary breast salivary gland-type carcinoma has weak evidence to support its management due to its rare occurrence and limited data regarding its clinicopathological features and prognosis. Therefore, this study aimed to assess clinicopathological features and prognosis for this type of carcinoma diagnosed over the past decade and compared those to the common breast invasive carcinoma of no special type (NST).
This study used the Surveillance, Epidemiology, and End Results (SEER) database to extract data regarding primary breast salivary gland-type carcinoma. Using a propensity score-matching approach, the prognosis was compared with invasive carcinoma, NST.
This study included 488 cases of salivary gland-type carcinoma and 375,660 cases of invasive carcinoma, NST, giving an occurrence ratio of 1 to 770. Adenoid cystic carcinoma (81%) formed the majority of salivary gland-type carcinoma, followed by secretory carcinoma (13%). For salivary gland-type carcinoma, acinic cell carcinoma histological type, tumor grade 3, HER2-overexpressed status, and higher AJCC stage groups were significant worse prognostic factors for breast cancer-specific survival in univariate analyses (p < 0.05). Nonetheless, tumor grade 3 and higher AJCC stage groups remained as significant independent prognostic factors in multivariate analysis (p < 0.05). The apparent better breast cancer-specific survival of salivary gland-type carcinoma as compared to that of invasive carcinoma, NST, was diminished following adjustment for differences in baseline clinicopathological features and treatment-related variables.
This study suggests that when managing primary breast salivary gland-type carcinoma, greater emphasis should be given to the tumor grade and AJCC stage group in addition to acinic cell carcinoma histological type and HER2 overexpression. Conventional prognostic factors are important as salivary gland-type carcinoma had similar prognosis as invasive carcinoma, NST, following adjustment for confounding variables.
原发性乳腺涎腺型癌由于其罕见的发生和有限的数据,其管理证据不足,包括临床病理特征和预后。因此,本研究旨在评估过去十年诊断的此类癌的临床病理特征和预后,并与常见的非特殊型浸润性乳腺癌(NST)进行比较。
本研究使用监测、流行病学和最终结果(SEER)数据库提取原发性乳腺涎腺型癌的数据。使用倾向评分匹配方法,比较与浸润性癌、NST 的预后。
本研究纳入了 488 例涎腺型癌和 375660 例浸润性癌、NST,发生率为 1 比 770。腺样囊性癌(81%)是涎腺型癌的主要类型,其次是分泌型癌(13%)。对于涎腺型癌,在单因素分析中,组织学类型为腺泡细胞癌、肿瘤分级 3 级、HER2 过表达状态和更高的 AJCC 分期组是乳腺癌特异性生存的显著不良预后因素(p<0.05)。然而,肿瘤分级 3 级和更高的 AJCC 分期组在多因素分析中仍然是独立的预后因素(p<0.05)。调整基线临床病理特征和治疗相关变量后,涎腺型癌的乳腺癌特异性生存率明显优于浸润性癌、NST。
本研究表明,在管理原发性乳腺涎腺型癌时,除了腺泡细胞癌组织学类型和 HER2 过表达外,还应更加关注肿瘤分级和 AJCC 分期组。在调整混杂变量后,涎腺型癌的预后与浸润性癌、NST 相似,传统的预后因素仍然很重要。